InMed Pharmaceuticals's total assets for Q4 2025 were C$15.65M, an increase of 68.60% from the previous quarter. INM total liabilities were C$2.15M for the fiscal quarter, a -4.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.